CMS gives the OK to Maryland Medicaid waiver, allowing diabetes management, dental care demonstrations

Dollar bill with a hole in Washington's face on it and the word "Medicaid" in its place
CMS has approved a Medicaid waiver request from Maryland. (zimmytws/GettyImages)

The Trump administration has approved a waiver request from Maryland, allowing the state to test several wellness and access projects in its Medicaid program. 

Under the approval (PDF), the Centers for Medicare & Medicaid Services will allow Maryland to amend its Health Choice managed care program to test projects aimed at expanding access to substance abuse treatment, dental care and better managing diabetes. 

Approved demonstrations must adhere to the goals of Medicaid, which is to offer medical assistance to low-income populations. In its letter, CMS said it determined that the various demonstrations included in the waiver request would likely improve access and boost patient outcomes. 

Conference

13th Partnering with ACOS & IDNS Summit

This two-day summit taking place on June 10–11, 2019, offers a unique opportunity to have invaluable face-to-face time with key executives from various ACOs and IDNs from the entire nation – totaling over 3.5 million patients served in 2018. Exclusively at this summit, attendees are provided with inside information and data from case studies on how to structure an ACO/IDN pitch, allowing them to gain the tools to position their organization as a “strategic partner” to ACOs and IDNs, rather than a merely a “vendor.”

“CMS has determined this amendment is likely to promote Medicaid objectives, and the expenditure and waiver authorities sought are necessary and appropriate to carry out the demonstration,” the agency said. 

RELATED: Maryland’s global budget program falls short of expectations in several key metrics 

The state’s initial diabetes care pilot expired on Jan. 1, so the waiver approval will allow it to further extend the demonstration. Under the Diabetes Prevention Program, patients will be paired lifestyle coaches who help them build and maintain healthy nutrition and fitness habits. 

In addition, the approval will allow Maryland to test a dental benefit for dual eligible beneficiaries between the ages of 21 and 65. The pilot would provide preventive and basic restorative dental care to this population, and in the letter, CMS highlighted the link between oral and physical health. 

The waiver approval will also allow the state to grow its substance use disorder treatment coverage and grow its family planning program for women on Medicaid of childbearing age. 

RELATED: The 4 biggest Medicaid controversies in 2018 

CMS has made state flexibility in Medicaid a priority under President Donald Trump, but the approach has been controversial, as work requirements in the program have been approved in eight states, most recently in Ohio

The waiver is an amendment to the ongoing one-of-a-kind waiver that allows Maryland's all-payer payment model that aims to coordinate care between providers and promote patient outcomes. It was expanded by the Trump administration in 2018

In defense of the section 1115 waivers, which includes both the work requirements and Maryland’s demonstration projects, CMS Administrator Seema Verma posted a fiery blog post and new guidance that aims to provide guardrails and monitoring tools to track how well these waivers are working. 

In the post, Verma said the agency “recognizes that not everyone supports our efforts to prioritize local control.” The waivers, she said, offer a crucial opportunity to test new strategies in Medicaid. 

“Through these efforts, we can collect and build an important body of evidence that will support continuous program improvement and new generations of good ideas,” she wrote. 

Suggested Articles

The country will see a shortage of up to nearly 122,000 physicians by 2032, according to a report from the Association of American Medical Colleges.

Dr. Asaf Bitton has been tapped as the executive director at Ariadne Labs.

Centene Corporation posted a significant boost in earnings and revenue over the first quarter of 2019 compared to a year prior.